🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Reconstitution and storage guide — evidence-based best practices

Reconstitution and storage guide — evidence-based best practices

SarahChen_PharmD Tue, Jun 2, 2026 at 4:11 AM 9 replies 292 viewsPage 1 of 2
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Jun 2, 2026 at 4:11 AM#1

This is the version of the explanation I wish somebody had given me, written down before I forget what confused me. It is about the dosing arithmetic, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Do it in two steps and it stops being confusing. First concentration: 10mg into 2ml is 5mg/ml. Then volume: a 0.5mg dose is 0.5 ÷ 5 = 0.1ml. Then units, and this is where people go wrong — a U-100 syringe is graduated in hundredths of a millilitre, so 0.1ml is 10 units. The word "units" has nothing to do with milligrams; it is a volume marking that exists because insulin happens to come at 100 units per ml.

The condition it depends on

The arithmetic is right and one caveat matters: a U-40 syringe changes the markings, not the volumes. If someone hands you U-40 and you read it as U-100 you will be 2.5 times out, and that error has a direction — it is always an overdose.

The practical version

The three numbers to write on the vial: total mg, total ml, and mg per ml. Everything else is division. And the sanity check is that dose volume times number of doses should be less than the volume you put in, because dead space takes the difference.

What I am not sure about

The bit I cannot resolve on my own is how much material I am losing to dead space, and whether that explains why a 10mg vial gives me nine usable draws rather than ten. Not looking for reassurance. Looking for the part I have got wrong.

— SarahChen_PharmD · corrections welcome and will be edited into this post with credit
30 0Dr.ObesityLA, NurseKim_ATL, paul_denver and 27 others
Reply Quote Save Share Report
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Jun 2, 2026 at 4:40 AM#2
SarahChen_PharmD said:
Do it in two steps and it stops being confusing.

Agreeing with SarahChen_PharmD, and the qualification matters more than the agreement. Concentration choice is a precision decision, not a preference. Reconstitute high and every dose is a tiny volume where one unit of syringe error is a large fraction of the dose. Reconstitute low and you get more graduations per dose, so the same hand tremor costs proportionally less. Against that, more diluent means more benzyl alcohol and a shorter comfortable in-use window.

That is the short version; the long version is somebody else's post.

Last edited: Jun 2, 2026 at 5:40 AM
29 24AmyNC_wife, SkepticalSean, Dr.CardioMD and 26 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Jun 2, 2026 at 5:09 AM#3
SarahChen_PharmD said:
Do it in two steps and it stops being confusing.

I am going to disagree with reconstituting low as a general rule. More diluent, more punctures, more in-use days at room temperature, and the stability trade-off is real. Precision is not the only variable being optimised.

That is the short version; the long version is somebody else's post.

28 23MikeNYC_runner and 25 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jun 2, 2026 at 5:38 AM#4

Taking the question as asked, rather than the general version of it. Dead space is the answer to the missing dose. A fixed-needle insulin syringe holds a few microlitres in the hub and needle after the plunger bottoms out, and on small draws that is a measurable percentage of every dose. Across ten draws it adds up to most of an eleventh, which is exactly the "nine draws from a ten-dose vial" complaint. Luer-lock syringes are worse; low-dead-space fixed-needle designs are better.

27 22dan_philly, MeganSA_TX, LarryQC_SD and 24 others
Reply Quote Save Share Report
FranDenver
Member
267
1,123
Oct 2024
Denver, CO
Jun 2, 2026 at 8:18 AM#5
RetaRick_CA said:
Concentration choice is a precision decision, not a preference.

Agreed, and light exposure is a real but secondary factor. Keep it in the carton; do not build a protocol around it.

Last edited: Jun 2, 2026 at 2:18 PM
26 21GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 23 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register